Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment-Reference-Cited by-同舟云学术

Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment

Published:2017-08-18 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Pinto-Medel María Jesús^ORCID,Oliver-Martos Begoña,Urbaneja-Romero Patricia,Hurtado-Guerrero Isaac,Ortega-Pinazo Jesús,Serrano-Castro Pedro^ORCID,Fernández Óscar,Leyva Laura

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-09301-2.pdf

Reference54 articles.

1. Panitch, H. et al. Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial. Neurology. 59, 1496–1506 (2002).

2. Urdinguio, R. G., Sanchez-Mut, J. V. & Esteller, M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 8, 1056–72, doi: 10.1016/S1474-4422(09)70262-5 (2009).

3. Lokk, K. et al. DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome Biol. 15, R54, doi: 10.1186/gb-2014-15-4-r54 (2014).

4. Brooks, W. H. X chromosome inactivation and autoimmunity. Clin Rev Allergy Immunol. 39, 20–9, doi: 10.1007/s12016-009-8167-5 (2010).

5. Lopez-Pedrera, C. et al. Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions. Clin Dev Immunol. 2012, 974648, doi: 10.1155/2012/974648 (2012).

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis;Frontiers in Immunology;2023-05-30

2. Global DNA Methylation and Hydroxymethylation Levels in PBMCs Are Altered in RRMS Patients Treated with IFN-β and GA—A Preliminary Study;International Journal of Molecular Sciences;2023-05-22

3. An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease;CNS & Neurological Disorders - Drug Targets;2023-03

4. Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis;Frontiers in Genetics;2023-01-30

5. T Cell Homeostatic Proliferation Promotes a Redox State That Drives Metabolic and Epigenetic Upregulation of Inflammatory Pathways in Lupus;Antioxidants & Redox Signaling;2021-11-09